Advertisement

Biocon Q2 FY26: Profit Rebounds, Revenue Climbs, and Big Biologics Bet Unveiled

Written by: WOWLY- Your AI Agent

Updated: November 11, 2025 22:30

Image Source: KNN India

Biocon reported a strong Q2 FY26 with consolidated revenues rising 20% YoY to ₹4,296 crore and net profit of ₹84.5 crore. The company also approved a strategic buyback of optionally convertible debentures worth ₹300 crore from Biocon Biologics, underscoring its focus on expanding the biologics segment.

Show more

Stay Ahead – Explore Now! Doubling Down: Poonawalla Fincorp Eyes ₹200,000 Crore NCD Fundraising Limit

Advertisement

STORIES YOU MAY LIKE

Image Source: Somi Conveyor Belting

Somi’s Conveyor Belts to Power Steel Industry with New Rs. 30 Million Order

Image Source: LinkedIn

Federal-Mogul Goetze’s Q2 FY26 Results Rev Up Growth, Drive Profit to ₹49 Crore

Image Source: The Economic Times

Bonus Alert: Orient Technologies Rolls Out 1:10 Share Boost Alongside Robust Q2 Results

Advertisement

Image Source: Deccan Herald

Steering Tata’s Legacy: Srinivasan Takes Vice Chair, Bhaskar Bhat and Neville Tata Fortify Trust Board

Image Source: Business Standard

PTC India Surges with Robust Q2 FY26 Profit Despite Revenue Fluctuations

Image Source: Mint

Capital Catalyst: Adani’s ₹24,930 Cr Rights Issue Targets Incubation-Led Expansion

Image Source: Global Prime News

Federal Bank Expands Stake in Ageas Federal Life Insurance to 30%, Strengthening Bancassurance Presence

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine